Eight officer departures, three delisting risks in 72-hour filing window

Eight officer departures, three delisting risks in 72-hour filing window

Eight senior officers departed from major and mid-cap companies in a concentrated filing window on 2026-05-08, while three smaller firms face delisting pressure. Edwards Lifesciences (EW), FedEx (FDX), Baxter International (BAX), ADT (ADT), Pool Corp (POOL), Nu Skin Enterprises (NU), Crescent Capital BDC (CCAP), and Cryo Cell International (CRYC) each disclosed officer departures via Item 5.02 8-K filings. Separately, the week's top-flagged cohort features LRHC La Rosa Holdings (delisting risk, restatement signals), QETA Quetta Acquisition Corp (three delisting alerts), and smaller-cap firms CETY Clean Energy Technologies and ARAI Arrive AI showing mixed restatement and delisting flags. The clustering of executive moves among large-cap healthcare and logistics names lacks obvious thematic explanation from available filings. Watch for successor announcements and any material function gaps at departing positions.